These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19658317)

  • 1. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM; Buchner V; Field RW; Scott BL
    Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
    Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
    Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
    Lombardi G; Germain C; Uren J; Fiorillo MT; du Bois RM; Jones-Williams W; Saltini C; Sorrentino R; Lechler R
    J Immunol; 2001 Mar; 166(5):3549-55. PubMed ID: 11207315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
    J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.
    Snyder JA; Demchuk E; McCanlies EC; Schuler CR; Kreiss K; Andrew ME; Frye BL; Ensey JS; Stanton ML; Weston A
    J R Soc Interface; 2008 Jul; 5(24):749-58. PubMed ID: 17956852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
    J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.
    Silveira LJ; McCanlies EC; Fingerlin TE; Van Dyke MV; Mroz MM; Strand M; Fontenot AP; Bowerman N; Dabelea DM; Schuler CR; Weston A; Maier LA
    J Immunol; 2012 Oct; 189(8):4014-23. PubMed ID: 22972925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR; Mack DG; Falta MT; Maier LA; Sullivan AK; Joslin FG; Martin AK; Freed BM; Kotzin BL; Fontenot AP
    J Immunol; 2005 Nov; 175(10):7029-37. PubMed ID: 16272364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of sensitivity to beryllium in mice.
    Tarantino-Hutchison LM; Sorrentino C; Nadas A; Zhu Y; Rubin EM; Tinkle SS; Weston A; Gordon T
    J Immunotoxicol; 2009 Jun; 6(2):130-5. PubMed ID: 19589099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Cragle DL; Tankersley WG; Wells SM; Newman LS; Maier LA
    Occup Environ Med; 2011 Nov; 68(11):842-8. PubMed ID: 21460389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in identifying beryllium sensitization and disease.
    Middleton D; Kowalski P
    Int J Environ Res Public Health; 2010 Jan; 7(1):115-24. PubMed ID: 20195436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
    J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
    Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention.
    Bartell SM; Ponce RA; Takaro TK; Zerbe RO; Omenn GS; Faustman EM
    Risk Anal; 2000 Feb; 20(1):87-99. PubMed ID: 10795342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
    Richeldi L; Sorrentino R; Saltini C
    Science; 1993 Oct; 262(5131):242-4. PubMed ID: 8105536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
    Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
    Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.